2023年度国家自然科学基金药物学学科合成药物化学研究项目申请与资助情况述评  

Analysis of the proposal application and funding of National Natural Science Foundation of China in the field of synthetic medicinal chemistry in 2023

作　　者：张青扬 张泉 韩立炜[1] ZHANG Qing-yang;ZHANG Quan;HAN Li-wei(Department of Health Sciences,National Natural Science Foundation of China,Beijing 100085,China;Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;College of Pharmacy,Nankai University,Tianjin 300350,China)

机构地区：[1]国家自然科学基金委员会医学科学部,北京100085 [2]中国医学科学院、北京协和医学院药物研究所,北京100050 [3]南开大学药学院,天津300350

出　　处：《药学学报》2024年第10期2717-2722,共6页Acta Pharmaceutica Sinica

摘　　要：合成药物化学在新药研发中扮演着至关重要的角色。本文介绍了2023年度国家自然科学基金药物学学科合成药物化学相关申请代码H3401和H3407面上项目、青年科学基金项目和地区科学基金项目的申请与资助情况,分析了2023年度申请项目的研究热点,并针对申请项目中存在的问题,为合成药物化学项目申请人提出建议,以期更好地发挥合成药物化学在新药研发过程中的作用,持续推进我国原创新药研发的高质量发展。Synthetic medicinal chemistry plays a crucial role in the research and development of new drugs.This article overviewed the proposal application and funding of the General Program,Young Scientist Fund and Fund for Less Developed Regions of National Natural Science Foundation of China related to synthetic medicinal chemistry in application codes H3401 and H3407 in 2023.It also analyzed the hotspots of the applied projects of synthetic medicinal chemistry in 2023 and provided suggestions to address the current challenges,which aimed to further exert the role of synthetic medicinal chemistry in the development of new drugs and continuously promote the high-quality development of China's original new drug research.

关 键 词：国家自然科学基金 药物学 合成药物化学 科学问题 项目分析 

分 类 号：R914[医药卫生—药物化学]